ADL Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- ADL Biopharma's estimated annual revenue is currently $36M per year.
- ADL Biopharma's estimated revenue per employee is $201,000
Employee Data
- ADL Biopharma has 179 Employees.
ADL Biopharma's People
| Name | Title | Email/Phone |
|---|
ADL Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is ADL Biopharma?
ADL BioPharma's experience in a leading position in the biopharmaceutical industry spans 6 decades. The company's activity is mostly centred on two pivots: the development and production of active therapeutic substances (mainly beta-lactam active ingredients), and the development and manufacture on contract of products and intermediates obtained from fermentation processes for third parties in the food, cosmetic and biotechnology industries. What we offer The R&D, Quality and Production Units at ADL BioPharma offer comprehensive support for our customer's projects, from the development of the process to its industrial scaling up, complying, upon demand, with the requirements established by the Good Manufacturing Practice system (GMP). We carry out projects that go from minimum amounts measured in grams to several tons, providing technical support throughout and in strict compliance with the applicable regulations.
keywords:N/A
N/A
Total Funding
179
Number of Employees
$36M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in León
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 275 | 5% | N/A |